Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,022 public trials 2,030 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

NCT01336933

Conditions
Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • Stanford University Stanford, California, United States
  • Emory University School Of Medicine Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

NCT00352027

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • Maine Children's Medical Center Portland, Maine, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)

NCT02312258

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Robert A Moss MD FACP Inc Fountain Valley, California, United States
  • UCLA Medical Hematology and Oncology Los Angeles, California, United States
  • North County Oncology Medical Clinic Inc Oceanside, California, United States
  • Ventura County Hematology Oncology Specialists Oxnard, California, United States
View all 275 locations
View Trial Details
Completed

Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT03309878

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details

Related conditions